The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel Article

cited authors

  • Hensing, TA; Peterman, AH; Schell, MJ; Lee, JH; Socinski, MA

authors

Publication Date

  • August 15, 2003

webpage

published in

category

keywords

  • age
  • drug therapy
  • nonsmall cell lung carcinoma
  • performance status
  • survival
  • toxicity

start page

  • 779

end page

  • 788

volume

  • 98

issue

  • 4